Novozymes CFO: Powerful momentum in bioenergy division
Comprehensively, we are seeing a powerful momentum in the division, says the company's chief financial officer.
BY RITZAU FINANS
Bioenergy sales, which for Novozymes consists of enzyme sales for bioethanol production, showed an organic growth rate of 5 percent in the fourth quarter of 2018.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novozymes' bioenergy division continues to grow
For subscribers
Novozymes' bioenergy division goes forward
For subscribers
